| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |